Cumberland Pharmaceuticals Inc. (CPIX) ownership: Top institutional holder: Ikarian Capital, LLC ($1.80M). Insider activity: Net Seller (1 buys, 11 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Ikarian Capital, LLC | 553153.00 | $1.80M | 2026-03-31 |
| VANGUARD GROUP INC | 411786.00 | $1.64M | 2025-12-31 |
| RENAISSANCE TECHNOLOGIES LLC | 470696.00 | $1.53M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 361759.00 | $1.18M | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 276359.00 | $898167.00 | 2026-03-31 |
| PERCEPTIVE ADVISORS LLC | 196978.00 | $640179.00 | 2026-03-31 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 163468.00 | $531271.00 | 2026-03-31 |
| BOOTHBAY FUND MANAGEMENT, LLC | 127694.00 | $415006.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-03-18 | |
| Sell | null | 2026-03-18 | |
| Sell | null | 2026-03-18 | |
| Sell | null | 2026-03-18 | |
| Sell | null | 2026-03-18 | |
| Sell | null | 2026-03-18 | |
| Sell | null | 2026-03-18 | |
| Sell | null | 2026-03-18 |
Back to CPIX overview · CPIX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.